These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phage therapy: a reappraisal of bacteriophages as antibiotics. Inal JM Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433 [TBL] [Abstract][Full Text] [Related]
3. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Hanlon GW Int J Antimicrob Agents; 2007 Aug; 30(2):118-28. PubMed ID: 17566713 [TBL] [Abstract][Full Text] [Related]
4. Phage therapy: past history and future prospects. Carlton RM Arch Immunol Ther Exp (Warsz); 1999; 47(5):267-74. PubMed ID: 10604231 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophage therapy: an alternative to conventional antibiotics. Mathur MD; Vidhani S; Mehndiratta PL J Assoc Physicians India; 2003 Jun; 51():593-6. PubMed ID: 15266928 [TBL] [Abstract][Full Text] [Related]
6. [Phagotherapy of postoperative suppurative-inflammatory complications in patients with neoplasms]. Kochetkova VA; Mamontov AS; Moskovtseva RL; Erastova EI; Trofimov EI; Popov MI; Dzhubalieva SK Sov Med; 1989; (6):23-6. PubMed ID: 2799488 [TBL] [Abstract][Full Text] [Related]
7. Bacteriophage therapy in children: facts and prospects. Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009 [TBL] [Abstract][Full Text] [Related]
9. Reinventing phage therapy: are the parts greater than the sum? Fischetti VA; Nelson D; Schuch R Nat Biotechnol; 2006 Dec; 24(12):1508-11. PubMed ID: 17160051 [TBL] [Abstract][Full Text] [Related]
14. Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Kutateladze M; Adamia R Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181 [TBL] [Abstract][Full Text] [Related]
16. Revisiting phage therapy: new applications for old resources. Nobrega FL; Costa AR; Kluskens LD; Azeredo J Trends Microbiol; 2015 Apr; 23(4):185-91. PubMed ID: 25708933 [TBL] [Abstract][Full Text] [Related]
17. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics. Ahmad SI Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy. Ryan EM; Gorman SP; Donnelly RF; Gilmore BF J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540 [TBL] [Abstract][Full Text] [Related]
19. [Factors of bacteriophage resistance to cellular nucleases in phagotherapy of microbial infections]. Nikol'skaia II; Debov SS Vestn Akad Med Nauk SSSR; 1984; (8):41-8. PubMed ID: 6093404 [No Abstract] [Full Text] [Related]
20. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Burrowes B; Harper DR; Anderson J; McConville M; Enright MC Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]